Bayer is dedicated to providing treatment options for people living with rare, serious and life-threatening hematologic diseases. Bayer has been a committed partner to the hemophilia community delivering therapeutic options, educational and support programs and continuing research designed to meet the needs of patients throughout their life journey.
P.O. Box 207
Pittsburgh, Pennsylvania 15230-0207